Skip to content
10-Q

Quarterly Report

Zomedica Corp. ZOMDF

0001558370-24-014859

← back to feed
Filed
Nov 7, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 7, 2024 979.95M sh
Cash And Equivalents Q3 2024 · Sep 30, 2024 $9.75M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $12.95M
Current Liabilities Q3 2024 · Sep 30, 2024 $8.06M
Current Liabilities Q3 2024 · Dec 31, 2023 $9.03M
Total Liabilities Q3 2024 · Sep 30, 2024 $11.27M
Total Liabilities Q3 2024 · Dec 31, 2023 $13.18M
Current Assets Q3 2024 · Sep 30, 2024 $87.27M
Current Assets Q3 2024 · Dec 31, 2023 $99.88M
Total Assets Q3 2024 · Sep 30, 2024 $214.12M
Total Assets Q3 2024 · Dec 31, 2023 $253.2M
Shares Diluted Q3 2024 · Sep 30, 2023 979.95M sh
Shares Diluted Q3 2024 · Sep 30, 2023 979.95M sh
Capex restated Q3 2024 · Sep 30, 2023 $9.3M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$10.96M
Stockholders Equity Q3 2024 · Sep 30, 2023 $260.88M
Stockholders Equity Q3 2024 · Jun 30, 2023 $259.48M
Stockholders Equity Q3 2024 · Dec 31, 2022 $267.39M
Eps Diluted restated Q3 2024 · Sep 30, 2023 $0.00
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$0.01
Eps Basic restated Q3 2024 · Sep 30, 2023 $0.00
Eps Basic restated Q3 2024 · Sep 30, 2023 −$0.01
Rd Expense Q3 2024 · Sep 30, 2023 $867K
Rd Expense Q3 2024 · Sep 30, 2023 $2.65M
Net Income Q3 2024 · Sep 30, 2023 −$491K
Net Income Q3 2024 · Sep 30, 2023 −$12.12M
Operating Income Q3 2024 · Sep 30, 2023 −$5.95M
Operating Income Q3 2024 · Sep 30, 2023 −$20.2M
Gross Profit Q3 2024 · Sep 30, 2023 $4.36M
Gross Profit Q3 2024 · Sep 30, 2023 $12.25M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $1.99M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $5.6M
Revenue Q3 2024 · Sep 30, 2023 $6.35M
Revenue Q3 2024 · Sep 30, 2023 $17.85M